Biomarkers of inflammation in persons with chronic tetraplegia.

Abstract

In addition to lung volume restriction, individuals with chronic tetraplegia exhibit reduced airway caliber and bronchodilator responsiveness similar to persons with asthma. In asthma, airflow obstruction is closely linked to airway inflammation. Conversely, little is known regarding the airway inflammatory response in tetraplegia. To compare levels of biomarkers of inflammation in exhaled breath condensate (EBC) and serum in subjects with chronic tetraplegia, mild asthma, and able-bodied controls.Prospective, observational pilot study. Thirty-four subjects participated: tetraplegia (n = 12), asthma (n = 12), controls (n = 10). Biomarkers in EBC [8-isoprostane (8-IP), leukotriene B4 (LT-B4), prostaglandin E2 (PG-E2), tumor necrosis factor alpha (TNF-α), interleukin 6 (IL-6)] and serum (8-IP, LT-B4, TNF-α, IL-6) were determined using commercially available EIA kits (Cayman Chemical Company, Ann Arbor, MI). Separate, one-way ANOVA with Bonferroni's post-hoc analyses were performed to determine group differences in demographic and dependent variables [EBC and serum biomarkers, fractional exhaled nitric oxide (FeNO), pulmonary function parameters, and specific airway conductance (sGaw)]. The tetraplegia group had significantly elevated 8-IP levels in EBC compared to the asthma (68 ± 38 versus 21 ± 13 pg ml(-1); p < 0.001) and control groups (22 ± 13 pg ml(-1); p < 0.01), respectively. FeNO levels were significantly elevated in the asthma compared to the control group (26 ± 18 versus 11 ± 4 ppb; p < 0.05), and trended higher than levels in the tetraplegia group (15 ± 6; p = 0.08). Levels of serum biomarkers did not differ significantly among groups. Through analysis of EBC, levels of 8-IP were significantly elevated compared to levels found in individuals with mild asthma and healthy controls. Further studies are needed to extend upon these preliminary findings that suggest the presence of airway inflammation in subjects with chronic tetraplegia, and how this relates to pulmonary dysfunction in this population.

• Authors: Miroslav Radulovic, William A Bauman, Jill M Wecht, Michael LaFountaine, Nighat Kahn, Joshua Hobson, Kamaldeep Singh, Christopher Renzi, Christina Yen, Gregory J Schilero
• Journal: Journal of breath research (J Breath Res) Vol. 9 Issue 3 Pg. 036001 (May 14 2015) ISSN: 1752-7163 [Electronic] England
• PMID: 25971935 (Publication Type: Journal Article, Observational Study, Research Support, Non-U.S. Gov't)

Chemical References

• Biomarkers
• IL6 protein, human
• Interleukin-6
• Tumor Necrosis Factor-alpha
• Leukotriene B4
• 8-epi-prostaglandin F2alpha
• Nitric Oxide
• Dinoprost

Topics

• Asthma (blood, complications, physiopathology)
• Biomarkers (blood)
• Breath Tests
• Case-Control Studies
• Dinoprost (analogs & derivatives, blood)
• Exhalation
• Female
• Humans
• Inflammation (blood, complications, physiopathology)
• Interleukin-6 (blood)
• Leukotriene B4 (blood)
• Male
• Middle Aged
• Nitric Oxide (metabolism)
• Pilot Projects
• Prospective Studies
• Quadriplegia (blood, complications, physiopathology)
• Tumor Necrosis Factor-alpha (blood)